Neuse, Carl Jannes
Lomas, Oliver C.
Schliemann, Christoph
Shen, Yu Jia
Manier, Salomon
Bustoros, Mark http://orcid.org/0000-0002-4652-5449
Ghobrial, Irene M. http://orcid.org/0000-0001-7361-3092
Funding for this research was provided by:
Multiple Myeloma Research Foundation
Leukemia and Lymphoma Society
Article History
Received: 16 January 2020
Revised: 5 June 2020
Accepted: 9 June 2020
First Online: 10 July 2020
Compliance with ethical standards
:
: There was no commercial funding for this review. MB has advisory role and received Honoraria from Takeda and has received honoraria Dava Oncology. IMG has a consulting and advisory role with Celgene, Takeda, Bristol-Myers Squibb, Genentech, Janssen Pharmaceuticals, and Amgen, and has received research funding/honoraria from Celgene, Takeda, Bristol-Myers Squibb, Janssen Pharmaceuticals, and Amgen. The rest of the authors have no conflicts to disclose.